When GLP-1s Silence Hunger Cues

Logosofia no Dia a Dia · Oct 10, 2026 · 20m

One in eight American adults is on a GLP-1, and the drugs do physiologically much of what anorexia does — muting hunger signals at the level of the brainstem. New survey data in JAMA Psychiatry finds GLP-1 use and misuse running far higher among people with eating disorders than in the general population, while FDA labels list no eating disorder warning and a secret-shopper study found telehealth vendors shipping the medication with no clinician interaction at all. This episode works through the mechanism, the case reports, the regulatory gap, and a new Delphi consensus that reached 100%…